As shown in Figure 3D, only PD-1-positive PBLs from the patient are specifically activated to strongly release IFN-γ when exposed to autologous tumor cells, whereas PD-1-negative T cells release very little IFN-γ. The gene discussed is IFNG; the disease is neoplasm.